Table 3

Estimates of educational differentials in excess mortality from cancer among Norwegian men and women, by cancer site, according to different methods, 1960–1991†

Models for womenModels for men
1a1b2a2b1a1b2a2b
†The models also included age, period, subsite, stage, and histological type/grade (the latter three, when relevant, only in the excess mortality term). The subsite and histological control variables were as defined in table 2. Only effects relative to those with 7–9 years of education are shown. Differences of 0.03–0.05, when compared with results from model 1a, are in bold types, and those larger than 0.05 are in bold, underlined types. *Significant at the 0.05 level.
Stomach
10–121.000.990.991.000.95*0.94*0.94*0.94*
13–160.960.950.940.950.940.920.92* 0.91
17–0.850.83*0.84*0.84
Colon/rectum
10–120.87*0.86*0.86*0.87*0.95*0.93*0.94*0.93*
13–160.890.87*0.87*0.900.87*0.84*0.85*0.86*
17–0.83*0.78*0.80*0.83*
Pancreas
10–121.041.031.031.030.93*0.93*0.93*0.95
13–160.79*0.78*0.79* 0.76* 0.80*0.80*0.80*0.79*
17–1.041.031.031.04
Lung
10–121.041.031.031.030.93*0.92*0.93*0.93*
13–161.151.141.141.130.87*0.86*0.87*0.96*
17–0.82*0.80*0.81*0.80*
Breast
10–120.91*0.88*0.89*0.90*
13–0.76* 0.73* 0.75*0.76*
Cervix
10–121.051.03 1.02 1.05
13–0.910.89 0.87 0.96
Corpus uteri
10–120.96 0.93 0.92 0.98
13–0.89 0.84 0.84 0.92
Ovaries
10–121.000.990.990.99
13–0.910.900.900.89
Prostate
10–120.90*0.86*0.89*0.91*
13–160.96 0.89* 0.90* 0.94*
17–0.66* 0.56* 0.65* 0.70*
Bladder
10–120.83*0.81*0.83*0.81*0.89*0.85*0.88*0.87*
13–160.70* 0.66* 0.72*0.69*0.79* 0.74* 0.76* 0.79*
17–0.59* 0.49* 0.62*0.64*
Malignant melanoma
10–121.01 0.97 0.95 0.94 0.72*0.70* 0.75* 0.72*
13–160.77 0.71* 0.78* 0.69 0.58* 0.55* 0.62* 0.62*
17–0.60*0.55*0.59* 0.63*
Leukaemia
10–120.940.930.930.920.90*0.89*0.90*0.89*
13–160.840.840.840.840.81*0.80*0.81*0.82*
17–0.72*0.71*0.71*0.71*
All sites above
10–120.96*0.94*0.94*0.95*0.92*0.90*0.91*0.91*
13–160.86*0.84*0.85*0.86*0.88*0.85*0.86*0.87*
17–0.78* 0.73* 0.75*0.78*